Table 1. Bacteria Which Are Most Commonly Isolated from Synovial Fluid of Patients with Bacterial Arthritis*

 

Gram-positive strains

Staphylococcus aureus  

Staphylococcus epidermidis, and other coagulase negative staphylococci

Streptococci

                        Streptococcus pyogenes

                        Streptococcus pneumoniae

                        Streptococcus agalactiae

 

Gram-negative strains

            Neisseria gonorrhoeae

            Escherichia coli

            Neisseria meningitides

 * Any strain, including anaerobes, which causes bacteraemia may invade joint tissues and elicit bacterial arthritis

 

 

Table 2  Risk Factors for the Development of Septic Arthritis

Old age (>80 years)

Rheumatoid arthritis

Immunosuppressive therapy

Prosthetic joint

Previous intra-articular corticosteroid injection

Diabetes mellitus

Osteoarthritis

Low socioeconomic status

Alcoholism

Cutaneous ulcers

Trauma penetrating into the joint

 

 

Table 3 Differential Diagnosis for Acute Monoarthritis

___________________________________________________________

Septic arthritis

Gout

Pseudogout

Rheumatoid arthritis

Apatite-related arthropathy

Reactive arthritis

Lyme arthritis

Transient synovitis of the hip

Pigmented villonodular synovitis

Hemarthrosis

Neuropathic arthropathy

Osteoarthritis

Intra-articular injury (fracture, meniscal tear, osteonecrosis)

Metastatic carcinoma

________________________________________________________

 

 

Table 4. Bacterial Infections Associated with the Development of Reactive Arthritis

_____________________________________________________________________________

Enteritis caused by

            Salmonella

                        Various serovars

            Shigella

                        S. flexneri

                        S. dysenteriae

                        S. sonnei

            Yersinia          

                        Y. enterocolitica (especially O:3 and O:9)

                        Y. pseudotuberculosis

            Campylobacter

                        C. jejuni

                        C. coli

            Clostridium difficile

Urethritis caused by

            Chlamydia trachomatis

            Mycoplasma genitalium*

            Ureaplasma urealyticum*

Upper respiratory infection caused by

            Group A beta-haemolytic streptococcus**

            Chlamydia pneumoniae

____________________________________________________________________________      

* causes urethritis, but the role in reactive arthritis still discussed;

** typically causes acute rheumatic fever, but has been described to cause ‘reactive-like’ arthritis

 

Table 5. Clinical Features of Reactive Arthritis in Hospital Series

 

Number of joints,  range

 

1-24

Low back pain, range  (%)

2-67

X-ray sacroilitis, range (%)

11-20

Urethritis, mean, range (%)

4-93

Conjunctivitis, range  (%)

6-78

Iritis, range  (%)

6-17

Skin lesions, range (%)

  - erythema nodosum

  - pustules

  - keratodermia

4-14

Duration of arthritis, range, months

1-30

Chronic course (>12 months), range (%)

0-30

HLA-B27 + , range (%)

0-94

 

Table 6. Revised Jones Criteria for Acute Rheumatic Fever [8] 

Major manifestations

Minor manifestations

Laboratory findings

Carditis

 

Polyarthritis

Fever

 

Arthralgia

Elevated acute-phase reactants:

a) C-reactive protein (CRP)

b) Erythrocyte sedimentation rate (ESR)

 

Chorea

 

 

Previous rheumatic fever or rheumatic heart disease

 

Prolonged P-R interval in ECG

 

Erythema marginatum

 

Subcutaneous nodules

 

Supporting evidence of preceding streptococcal infection:

a) Increased ASO or other streptococcal antibodies

b) Positive throat culture for Group A-haemolytic streptococci

c) Recent scarlet fever

 

Table 7. Musculoskeletal Features of Borreliosis with Respect to Geographical Areas. Adapted from [9] 

Clinical symptom

Europe and Asia (B. afzelii, B. garinii, B. burgdorferi ss)

North America (B. burgdorferi ss)

Arthritis, acute

Oligoarthritis (less frequent)

Less intense joint inflammation

 

Oligoarthritis (more frequent)

More intense joint inflammation

 

Arthritis, chronic

Persisting arthritis less frequent

Treatment-resistant arthritis in about 10% of the patients

 

Table 8. Arthritis and Autoimmune Diseases Associated with Parvovirus B19 Infection

 

Type of arthritis

Other autoimmune features

Other manifestations

Acute

Chronic

Vasculitis

Antiphospholipid syndrome

SLE

Rash, haematological changes, hepatitis, myocarditis, myositis, CNS symptoms

______________________________________________________________________________

SLE, systemic lupus erythematosus; CNS, central nervous system

 

Table 9. Alphaviruses Related to Articular Symptoms. Adapted from [11] 

Virus

Clinical features

Epidemiological area

Chikungunya

Fever, arthralgia/arthritis, rash, myalgia, chronic joint pain, haemorrhagic symptoms, paresthesias

Africa, India, South East Asia, Philippines

Mayaro

Fever, arthralgia/arthritis, chronic joint pain, rash, myalgia, haemorrhagic symptoms

Trinidad, Surinam, Brazil, Colombia, Bolivia

O’nyong-nyong

Fever, arthralgia/arthritis, chronic joint pain, rash, myalgia, haemorrhagic symptoms, paresthesias

Uganda, Kenya, Tanzania, Malawi, Senegal

Barmah Forest

Fever, arthralgia/arthritis, rash, myalgia

Australia

Igbo Ora

Fever, arthralgia, rash, myalgia

Ivory Coast

Ross River

Fever, polyarthritis, chronic arthralgia,  rash, paresthesias, glomerulonephritis

Australia, New Guinea, Fiji, The Solomon Islands, American Samoa, South pacific Islands

Sindbis

Fever, rash, arthralgia/arthritis, paresthesias

Europe, Africa, Australia, Asia, Philippines

Ockelbo

Fever, arthralgia/arthritis, rash, chronic joint pain, paresthesias

Sweden, Norway

 

Pogosta

Fever, arthralgia/arthritis, chronic arthritis, rash,

Finland

 

Karelian fever

Fever, arthralgia, rash

Russia

 

Table 10. Antibiotic Treatment of Septic Arthritis. Adapted from  [4,16] 

Patient group

Antibiotic choice

No risk factors for atypical organism

Staphylococcal penicillin (e.g. cloxacillin or flucloxacillin) 2 g four times a day i.v.

Fusidic acid 500 mg three times a day p.o, or gentamicin i.v. may be added.

In the case of penicillin allergy, clindamycin 450-600 mg for times a day, or 2nd or 3rd generation cephalosporin may be given

High risk of Gram negative sepsis

2nd or 3rd generation cephalosporin (e.g. cefuroxime 1.5 g three times a day).

MRSA (methicillin resistant Staphylococcus aureus) risk

Vancomycin plus 2nd or 3rd generation cephalosporin

Suspected gonococcus or meningococcus

Ceftriaxone 1 g once a day (im. or iv) or similar drugs, depending on local policy/resistance

I.V. drug users

Discuss with microbiologist

Intensive therapy unit patients, known colonization of other organs

Discuss with microbiologist

 

Figure 1: Septic Arthritis

 

Figure 2: A Pustule at Early Phase of Disseminated Gonococcal Infection

 

Figure 3: A Pustule With Necrotic Centre In A Patient With

Disseminated Gonococcal Infection

 

Figure 4: Fulminant Knee Synovitis In A Patient With Reactive Arthritis

 

Figure 5: Dactylitis Of Left 2. Toe And Right 4. Toe

In A Patient With Reactive Arthritis

 

 

Figure 6: Skin Lesions In A Patient With Reactive

Arthritis Due To Salmonella Infection

 

 

Figure 7:  A Patient With Acute Gouty Arthritis In The Foot

 

 

Figure 8. Erythema Nodosum

 

 

Figure 9: Bilateral Hilar Lymphadenopathy In A Patient With Acute Sarcoidosis

 

Figure 10:. Clinical Approach  In A patient Who PresentsWith Fever and Acute Arthritis (A),

and With Fever, Arthritis, and Extra-Articular (B) Symptoms.

ReA=Reactive Arthritis; HIV=Human Immunodeficiency Virus; Gc=Gonococcal; EN=Erythema Nodosum; EM=Erythema Migrans.

 

Figure 11: Radiology Of The Ankle In A Patient With Septic Arthritis (Same Patient As In Fig. 1)

 

 

Figure 12: Radiology Of Left Knee In A Patient Rheumatoid Arthritis With

Septic Arthritis In A Knee With Prosthesis

 

 

 

Figure 13: Indium-111 Labeled Leucocyte Scan In A Patient With

Septic Arthritis (Same Patient As In Fig. 12)

 

 

 

Figure 14: Three-Phase Bone Scan With Technetium-99m Labeled

Diphosphonates In A Patient With Septic Arthritis (Same Patient As In Fig. 12)